TG Therapeutics, Inc.
USD55.91
+0.18 (+0.33%)
CEO
Michael S. Weiss
IPO Date
2010-05-03
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$55.89
Prev. Close
$55.72
Day Low
$54.50
Day High
$56.20
52W Low
$25.28
52W High
$57.38
Market Cap
$8.56B
Volume
0.28M
| 8,325 |
| $0.00 |
| 15 Jun 2026 | Hoberman Kenneth | director | A-Award | Acquired | 8,325 | $0.00 |
| 15 Jun 2026 | Echelard Yann | director | A-Award | Acquired | 8,325 | $0.00 |
| 15 Jun 2026 | Charney Laurence N | director | A-Award | Acquired | 8,325 | $0.00 |
| 29 Jan 2026 | Charney Laurence N | director | G-Gift | Disposed | 13,197 | $0.00 |
| 29 Jan 2026 | Charney Laurence N | director | G-Gift | Disposed | 30,000 | $0.00 |
| 9 Jan 2026 | WEISS MICHAEL S | director, officer: CEO | A-Award | Acquired | 622,000 | $0.00 |
| 9 Jan 2026 | Power Sean A | CFO | A-Award | Acquired | 90,000 | $0.00 |
| 25 Nov 2025 | Echelard Yann | director | S-Sale | Disposed | 5,000 | $32.57 |